,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,503602,6058,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,503602,6058,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,503602,6058,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,503602,6058,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,503602,6058,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,503602,6058,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,179,1,1,,503602,6058,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
7,357,2,1,,11111480,6058,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
8,410,1,5,,11111480,6058,Inactive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
9,411,2,1,,11111480,6058,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
10,444,1,1,,11111480,6058,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
11,445,3,1,,11111480,6058,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
12,446,1,1,,11111480,6058,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
13,447,1,1,,11111480,6058,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
14,448,1,2,,11111480,6058,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
15,450,1,2,,11111480,6058,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
16,451,1,2,,11111480,6058,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
17,526,1,1,,11111480,6058,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
18,530,1,1,,11111480,6058,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
19,584,1,3,,11111480,6058,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
20,585,1,4,,11111480,6058,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
21,587,1,5,,11111480,6058,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
22,588,1,4,,11111480,6058,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
23,589,1,3,,11111480,6058,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
24,590,1,3,,11111480,6058,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
25,591,1,4,,11111480,6058,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
26,592,1,6,,11111480,6058,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
27,593,1,4,,11111480,6058,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
28,594,1,4,,11111480,6058,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
29,595,1,3,,11111480,6058,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
30,596,1,2,,11111480,6058,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
31,597,1,3,,11111480,6058,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
32,603,1,2,,11111480,6058,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
33,605,1,2,,11111480,6058,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
34,607,1,3,,11111480,6058,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
35,662,1,1,,11111480,6058,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
36,875,1,2,,11111480,6058,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
37,879,1,2,,11111480,6058,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
38,879,1,2,,11111480,6058,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
39,881,2,2,,11111480,6058,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
40,883,1,3,,11111480,6058,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
41,884,1,2,,11111480,6058,Inactive,13435386.0,1576.0,1.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
42,885,1,2,,11111480,6058,Inconclusive,13435386.0,1576.0,1.0,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
43,886,1,2,,11111480,6058,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
44,886,1,2,,11111480,6058,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
45,887,1,2,,11111480,6058,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
46,889,1,3,,11111480,6058,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
47,891,1,2,,11111480,6058,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
48,892,1,2,,11111480,6058,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
49,893,1,2,,11111480,6058,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
50,893,1,2,,11111480,6058,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
51,895,1,2,,11111480,6058,Inactive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
52,899,1,2,,11111480,6058,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
53,900,1,3,,11111480,6058,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
54,901,1,2,,11111480,6058,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
55,902,1,2,,11111480,6058,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
56,912,1,2,,11111480,6058,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
57,914,1,3,,11111480,6058,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
58,915,1,3,,11111480,6058,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
59,917,1,3,,11111480,6058,Inactive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
60,918,1,3,,11111480,6058,Inconclusive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
61,923,1,2,,11111480,6058,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
62,924,1,2,,11111480,6058,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
63,925,1,2,,11111480,6058,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
64,926,1,2,,11111480,6058,Unspecified,38016895.0,7253.0,39.8107,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
65,927,1,3,,11111480,6058,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
66,928,1,2,,11111480,6058,Inactive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
67,938,1,2,,11111480,6058,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
68,943,1,2,,11111480,6058,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
69,944,1,2,,11111480,6058,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
70,945,1,4,,11111480,6058,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
71,954,1,2,,11111480,6058,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
72,957,1,2,,11111480,6058,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
73,958,1,2,,11111480,6058,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
74,959,1,4,,11111480,6058,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
75,992,1,3,,11111480,6058,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
76,995,1,2,,11111480,6058,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
77,997,1,2,,11111480,6058,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
78,998,1,2,,11111480,6058,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
79,1195,1,2,,48415835,6058,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
80,1452,1,1,,11111480,6058,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
81,1471,2,1,,11111480,6058,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
82,1851,1,2,,11111480,6058,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
83,1851,1,2,1.0,11111480,6058,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
84,1851,1,2,2.0,11111480,6058,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
85,1851,1,2,3.0,11111480,6058,Inconclusive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
86,1851,1,2,4.0,11111480,6058,Inactive,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
87,1851,1,2,5.0,11111480,6058,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
88,2660,1,1,,90341118,6058,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
89,2666,1,1,,90341118,6058,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
90,2667,1,1,,90341118,6058,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
91,2668,1,1,,90341118,6058,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
92,16770,3,4,,103183110,6058,Unspecified,,,,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Other,6887207.0,
93,16783,3,4,,103183110,6058,Unspecified,,,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Other,6887207.0,
94,16784,3,4,,103183110,6058,Unspecified,,,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Other,6887207.0,
95,16785,3,4,,103183110,6058,Unspecified,,,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Other,6887207.0,
96,45374,6,2,,103183110,6058,Active,,,41.6,EC50,Antiviral activity against HIV-1 in CEM-SS cells using XXT assay,Confirmatory,9207937.0,
97,45376,6,2,,103183110,6058,Unspecified,,,53.7,EC50,Antiviral activity against HIV-1ADA in CEM-SS cells using monocyte/macrophage cultures,Confirmatory,9207937.0,
98,45884,6,2,,103183110,6058,Unspecified,,,71.0,IC50,Antiviral activity against HIV-1 in CEM-SS cells using XXT assay,Confirmatory,9207937.0,
99,45885,6,2,,103183110,6058,Unspecified,,,100.0,IC50,Antiviral activity against HIV-1ADA in CEM-SS cells using monocyte/macrophage cultures,Confirmatory,9207937.0,
100,89002,5,2,,103183110,6058,Inactive,,,,,Compound was tested for binding of HIV-1 to CEM-ss cells; NI = No inhibition,Other,9207937.0,
101,106125,5,1,,103183110,6058,Unspecified,,,,,Effect on intracellular GSH content at 250 uM in human macrophage-derived monocytes (MDMs),Other,11354374.0,
102,134599,6,2,,103183110,6058,Unspecified,,,,,Lethal dose in mice,Other,6887207.0,
103,135982,3,5,,103183110,6058,Unspecified,,,,,"Percent survival at 15 min time interval between administration (225 mg/kg, ip) and irradiation* in mice",Other,6887207.0,
104,135984,3,4,,103183110,6058,Unspecified,,,,,"Percent survival at 1 hr time interval between administration (225mg/kg, ip) and irradiation* in mice",Other,6887207.0,
105,136114,3,5,,103183110,6058,Unspecified,,,,,"Percent survival at 2 hr time interval between administration (225 mg/kg, ip) and irradiation* in mice",Other,6887207.0,
106,158688,6,2,,103183110,6058,Unspecified,,,200.0,IC50,Inhibitory activity against Plasmodium falciparum,Confirmatory,9357523.0,
107,161899,5,4,,103183110,6058,Inactive,,,,,Compound was tested for effects on HIV-1 protease; NI = No inhibition,Other,9207937.0,
108,200145,5,4,,103183110,6058,Inactive,,,,,Compound was tested for the effect on HIV-1 Reverse Transcriptase; NI = No inhibition,Other,9207937.0,
109,251090,3,3,,103183110,6058,Unspecified,,,,,Percentage of cleavage in single stranded peptide nucleic acid was measured after treating with compound for 2 min; selectivity factor=1.5; PNA:DNA=5a:6,Other,15664802.0,
110,251108,3,4,,103183110,6058,Unspecified,,,,,Percentage of cleavage in single stranded peptide nucleic acid (PNA) DNA duplex was measured after treating with compound for 2 min; selectivity factor=1.5; PNA:DNA=5a:6,Other,15664802.0,
111,260538,3,3,,103183110,6058,Unspecified,,,,,Inhibition of lipid peroxidation of rat hepatic microsomal membrane lipids at 1 uM,Other,16309906.0,
112,284868,3,3,,103183110,6058,Unspecified,,,,,"Mortality rate in Fischer 344 rat at 1.6 mmol/kg, sc after 4 days",Other,17126019.0,
113,284869,3,3,,103183110,6058,Unspecified,,,,,"Gastrointestinal toxicity in Fischer 344 rat assessed as gastrointestinal ulceration at 1.6 mmol/kg, sc after 4 days",Other,17126019.0,
114,284870,3,3,,103183110,6058,Unspecified,,,,,"Body weight change per 100g in Fischer 344 rat at 1.6 mmol/kg, sc after 4 days",Other,17126019.0,
115,317227,3,3,,103183110,6058,Active,,,,,Depletion of lysosomal cystine in cystinotic fibroblasts GM00008 at 50 uM after 72 hrs,Other,18249536.0,
116,386623,4,8,,103183110,6058,Unspecified,313104181.0,6580.0,,,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells at 100 uM by confocal microscopy,Other,18788725.0,
117,463106,1,2,,90341118,6058,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
118,485295,1,2,,90341118,6058,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
119,485297,1,1,,90341118,6058,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
120,485298,1,1,,90341118,6058,Inactive,,,8.1995,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
121,485313,1,2,,90341118,6058,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
122,485342,1,2,,90341118,6058,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
123,485345,1,2,,90341118,6058,Inactive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
124,485366,1,2,,90341118,6058,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
125,485368,1,2,,90341118,6058,Inactive,72386991.0,3656265.0,,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
126,488772,1,1,,90341118,6058,Inconclusive,8659577.0,58819.0,18.8876,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
127,488773,1,2,,90341118,6058,Inactive,8659577.0,58819.0,5.3233,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
128,488816,1,1,,90341118,6058,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
129,488837,1,1,,90341118,6058,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
130,488949,1,2,,90341118,6058,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
131,488953,1,1,,90341118,6058,Inconclusive,187960037.0,10951.0,50.1187,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
132,488978,1,1,,90341118,6058,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
133,488981,1,1,,90341118,6058,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
134,488982,1,1,,90341118,6058,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
135,488983,1,1,,90341118,6058,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
136,493106,1,1,,90341118,6058,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
137,493107,1,1,,90341118,6058,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
138,493153,1,1,,90341118,6058,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
139,493153,1,1,,90341118,6058,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
140,493164,1,2,,90341118,6058,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
141,493164,1,2,,90341118,6058,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
142,493164,1,2,,90341118,6058,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
143,504327,1,1,,90341118,6058,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
144,504332,1,1,,90341118,6058,Active,168985070.0,,14.1254,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
145,504536,1,1,,90341118,6058,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
146,504547,1,1,,90341118,6058,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
147,504548,1,2,,90341118,6058,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
148,504810,1,2,,90341118,6058,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
149,504812,1,2,,90341118,6058,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
150,504836,1,2,,90341118,6058,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
151,504845,1,1,,90341118,6058,Inconclusive,86301163.0,5999.0,7.5193,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
152,504847,1,1,,90341118,6058,Inconclusive,63054845.0,7421.0,19.9526,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
153,504865,1,1,,90341118,6058,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
154,540256,1,2,,90341118,6058,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
155,540276,1,2,,11111480,6058,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
156,540276,1,2,,50111130,6058,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
157,540276,1,2,,90341118,6058,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
158,552755,2,3,,103183110,6058,Unspecified,,,,,Cytotoxicity against human cystinotic fibroblast at 50 uM after 72 hrs by alamar blue assay,Other,21147534.0,
159,552756,3,3,,103183110,6058,Active,,,,,Antinephropathic cystinosis activity in human cystinotic fibroblast assessed as decrease in cystine level at 50 uM after 24 hrs by Bradford reagent method,Other,21147534.0,
160,588220,2,3,,103183110,6058,Unspecified,,,,,Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset,Other,20020916.0,
161,588349,1,1,,90341118,6058,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
162,588378,1,1,,90341118,6058,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
163,588453,1,1,,90341118,6058,Inactive,8659577.0,58819.0,5.9728,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
164,588456,1,1,,90341118,6058,Inconclusive,8659577.0,58819.0,19.9526,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
165,588579,1,1,,90341118,6058,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
166,588795,1,1,,90341118,6058,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
167,589519,1,3,,103183110,6058,Unspecified,,,,,Cytotoxicity against human cystinotic Fibroblast at 50 uM for 72 hrs by Alamar blue assay,Other,21397500.0,
168,602332,1,1,,90341118,6058,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
169,602332,1,1,,124880761,6058,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
170,610690,1,3,,103183110,6058,Unspecified,,,,,Cytotoxicity against cystinotic human fibroblasts at 50 uM after 72 hrs by Alamar blue assay,Other,21536447.0,
171,610691,1,3,,103183110,6058,Active,,,,,Reduction of intralysosomal cystine in cystinotic human fibroblasts at 50 uM after 24 hrs by Bradford method relative to control,Other,21536447.0,
172,624030,1,2,,124880761,6058,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
173,624146,1,1,,90341118,6058,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
174,624147,1,1,,90341118,6058,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
175,624148,1,2,,90341118,6058,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
176,624149,1,1,,90341118,6058,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
177,624170,1,1,,124880761,6058,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
178,624172,1,1,,124880761,6058,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
179,624173,1,3,,124880761,6058,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
180,624455,1,1,,90341118,6058,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
181,625279,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
182,625280,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
183,625281,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
184,625282,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
185,625283,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
186,625284,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
187,625285,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
188,625286,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
189,625287,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
190,625288,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
191,625289,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
192,625290,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
193,625291,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
194,625292,1,3,,103183110,6058,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
195,651631,4,1,,144206643,6058,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
196,651632,4,1,,144206643,6058,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
197,651633,4,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
198,651634,4,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
199,651635,1,3,,90341118,6058,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
200,652048,1,2,,144206643,6058,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
201,652051,1,1,,144206643,6058,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
202,652106,1,1,,90341118,6058,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
203,686978,1,1,,144206643,6058,Inconclusive,79154014.0,55775.0,29.8554,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
204,686979,1,1,,144206643,6058,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
205,720516,2,1,,144206643,6058,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
206,720532,1,1,,144206643,6058,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
207,720533,1,1,,144206643,6058,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
208,720538,1,2,,90341118,6058,Inactive,220983390.0,410.0,,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
209,720552,2,1,,144206643,6058,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
210,720559,1,2,,90341118,6058,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
211,720572,1,2,,90341118,6058,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
212,720573,1,2,,90341118,6058,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
213,720634,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
214,720635,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
215,720637,2,1,,144206643,6058,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
216,720674,2,2,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
217,720675,2,2,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
218,720678,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
219,720679,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
220,720680,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
221,720681,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
222,720682,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
223,720683,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
224,720684,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
225,720685,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
226,720686,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
227,720687,2,2,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
228,720691,4,1,,144206643,6058,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
229,720692,3,1,,144206643,6058,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
230,720693,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
231,720719,2,1,,144206643,6058,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
232,720725,2,1,,144206643,6058,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
233,743012,3,1,,144206643,6058,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
234,743014,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
235,743015,3,1,,144206643,6058,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
236,743033,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
237,743035,2,1,,144206643,6058,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
238,743036,2,1,,144206643,6058,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
239,743040,3,1,,144206643,6058,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
240,743041,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
241,743042,3,1,,144206643,6058,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
242,743053,2,1,,144206643,6058,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
243,743054,2,1,,144206643,6058,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
244,743063,2,1,,144206643,6058,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
245,743064,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
246,743065,3,1,,144206643,6058,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
247,743066,3,1,,144206643,6058,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
248,743067,2,1,,144206643,6058,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
249,743069,2,1,,144206643,6058,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
250,743074,2,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
251,743075,2,1,,144206643,6058,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
252,743077,2,1,,144206643,6058,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
253,743078,2,1,,144206643,6058,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
254,743079,3,1,,144206643,6058,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
255,743080,3,1,,144206643,6058,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
256,743081,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
257,743083,3,1,,144206643,6058,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
258,743084,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
259,743085,3,1,,144206643,6058,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
260,743086,3,1,,144206643,6058,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
261,743091,2,1,,144206643,6058,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
262,743094,3,1,,144206643,6058,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
263,743122,2,1,,144206643,6058,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
264,743139,2,1,,144206643,6058,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
265,743140,2,1,,144206643,6058,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
266,743205,1,1,,90341118,6058,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
267,743205,1,1,,90341118,6058,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
268,743206,1,1,,90341118,6058,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
269,743206,1,1,,90341118,6058,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
270,743207,1,1,,90341118,6058,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
271,743207,1,1,,90341118,6058,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
272,743244,1,1,,90341118,6058,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
273,743244,1,1,,144206643,6058,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
274,1079931,1,1,,103183110,6058,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
275,1079932,1,1,,103183110,6058,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
276,1079933,1,1,,103183110,6058,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
277,1079934,1,1,,103183110,6058,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
278,1079935,1,1,,103183110,6058,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
279,1079936,1,1,,103183110,6058,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
280,1079937,1,1,,103183110,6058,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
281,1079938,1,1,,103183110,6058,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
282,1079939,1,1,,103183110,6058,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
283,1079940,1,1,,103183110,6058,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
284,1079941,1,1,,103183110,6058,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
285,1079942,1,1,,103183110,6058,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
286,1079943,1,1,,103183110,6058,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
287,1079944,1,1,,103183110,6058,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
288,1079945,1,1,,103183110,6058,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
289,1079946,1,1,,103183110,6058,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
290,1079947,1,1,,103183110,6058,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
291,1079948,1,1,,103183110,6058,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
292,1079949,1,1,,103183110,6058,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
293,1159580,2,1,,268735017,6058,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
294,1159580,2,1,,273002880,6058,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
295,1159607,2,1,,312995617,6058,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
296,1159620,1,1,,103183110,6058,Active,,,,,Summary of drug indications.,Other,,
297,1224859,2,1,,90341118,6058,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
298,1224863,1,1,,316919231,6058,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
299,1259344,1,1,,144206643,6058,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
300,1259407,1,1,,363901033,6058,Inactive,,,,,CCRIS mutagenicity studies,Other,,
301,1259408,1,1,,363894901,6058,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
302,1259409,1,1,,363901033,6058,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
303,1259423,1,2,,354787137,6058,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
304,1259423,1,2,,354966190,6058,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
